Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0841108948110358 0.0404779485802511 0.0941800362489092 0.0290326911458683
Stock impact report

Oncternal Therapeutics Announces Increased Focus of the Cirmtuzumab ROR1 Antibody Program on Mantle Cell Lymphoma

Oncternal Therapeutics, Inc. (ONCT)  More Company Research Source: Business Wire
Last oncternal therapeutics, inc. earnings: 8/8 04:01 pm Check Earnings Report
PDF - Increasing planned enrollment of patients with MCL in ongoing CIRLL Phase 1/2 clinical trial of cirmtuzumab with ibrutinib based on encouraging data presented at ASCO 2020- Meeting requested with FDA to discuss registration pathway for cirmtuzumab for patients with MCL SAN DIEGO--(BUSINESS WIRE)--Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced an updated clinical strategy for its investigational ROR1 monoclonal antibody, cirmtuzumab, that prioritizes development in mantle cell lymphoma (MCL), based on encouraging interim clinical results from the ongoing Cirmtuzumab and Ibrutinib targeting ROR1 for Leukemia and Lymphoma (CIRLL) Phase 1/2 clinical trial that were presented at the American Society of Clinical Oncology 2020 Annual Meeting (ASCO 2020) in May 2020.The Company reported a 58% complete response (CR) rate, a 83% overall best objective response rate (ORR), and a [Read more]
Impact snapshot Event time: ONCT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ONCT alerts

from News Quantified
Opt-in for
ONCT alerts

from News Quantified